BAAT Medical Celebrates FDA Breakthrough Device Designation for APEX R-FIX SYSTEM

BAAT Medical is thrilled to extend its heartfelt congratulations to Daniel Bonthuis of MUSC Health and the Apex Orthopedic Technologies team for their remarkable achievement in securing the coveted FDA Breakthrough Device Designation status for the APEX R-FIX SYSTEM.

daniel bonthius of apex technologies orthopedic medtech startup

Curious? check out these sources:
Venture Radar
Daniel Bonthius Business Profile

Or Join the conversation on LinkedIn
Go

This designation, granted by the U.S. Food and Drug Administration (FDA), recognizes the APEX R-FIX SYSTEM as a medical device with the potential to revolutionize the field of healthcare. The FDA Breakthrough Device Designation is reserved for devices that demonstrate substantial advantages over existing technologies in the diagnosis, treatment, or management of life-threatening or debilitating conditions.

The APEX R-FIX SYSTEM, developed through collaborative efforts, has proven its potential to significantly improve patient outcomes and advance the state of healthcare. BAAT Medical is proud to be part of this innovative endeavor and remains committed to furthering the cause of enhancing healthcare delivery.

We look forward to witnessing the positive impact that the APEX R-FIX SYSTEM will have on patients’ lives and the broader healthcare community, as we continue to shape the future of healthcare together.